LCGA-17

N/A

Report date: 2022/05/19 15:12:09
NME

Base Information

Drug NameLCGA-17
Drug Alias NameLCGA17
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionVoltage-gated calcium channel alpha2/delta subunit 1 modulators
TargetsVoltage-gated calcium channel alpha2/delta subunit 1
Therapy Area/IndicationsStress Disorders, Post-TraumaticDepressive Disorder, MajorAnxiety Disorders +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLactocore Group
China Registration ClassN/A

Develop Information

Active CompaniesLactocore Group
Inactive CompaniesN/A
Active IndicationsStress Disorders, Post-TraumaticDepressive Disorder, MajorAnxiety Disorders +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A